0001209191-21-042256.txt : 20210621 0001209191-21-042256.hdr.sgml : 20210621 20210621190429 ACCESSION NUMBER: 0001209191-21-042256 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210616 FILED AS OF DATE: 20210621 DATE AS OF CHANGE: 20210621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Farrell Robert E Jr CENTRAL INDEX KEY: 0001592280 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38940 FILM NUMBER: 211032516 MAIL ADDRESS: STREET 1: CAMBRIDGE DISCOVERY PARK STREET 2: 100 ACORN PARK DRIVE, 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Morphic Holding, Inc. CENTRAL INDEX KEY: 0001679363 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473878772 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 GATEHOUSE DRIVE A2 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 9787296480 MAIL ADDRESS: STREET 1: 35 GATEHOUSE DRIVE A2 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Morphic Holding, LLC DATE OF NAME CHANGE: 20160712 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-16 0 0001679363 Morphic Holding, Inc. MORF 0001592280 Farrell Robert E Jr C/O MORPHIC HOLDING, INC. 35 GATEHOUSE DRIVE, A2 WALTHAM MA 02451 0 1 0 0 SVP Finance and CAO Common Stock 2021-06-16 4 M 0 300 4.32 A 18234 D Common Stock 2021-06-16 4 S 0 300 65.0033 D 17934 D Common Stock 2021-06-18 4 M 0 200 4.32 A 18134 D Common Stock 2021-06-18 4 S 0 200 65.00 D 17934 D Stock Option (right to buy Common Stock) 4.32 2021-06-16 4 M 0 300 0.00 D 2028-12-14 Common Stock 3000 75444 D Stock Option (right to buy Common Stock) 4.32 2021-06-18 4 M 0 200 0.00 D 2028-12-14 Common Stock 200 75244 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.01 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option vests as to 2.0833% of the total shares monthly, beginning January 14, 2019, with 100% of the total shares vested and exercisable on December 14, 2022, subject to the reporting person's provision of service to the issuer on each vesting date. /s/ Robert Farrell, Jr. 2021-06-19